KAP Applauds Provincial Government Approach to Carbon Pricing

Dec 05, 2016

The President of Keystone Agricultural Producers is applauding the Premier's of Manitoba's commitment to ensure a provincial carbon pricing system will not hinder economic recovery.

In September the federal government announced that a carbon pricing system must be in place in all provinces by the end of 2018.

Manitoba Premier Brian Pallister has stated a carbon tax must not unduly impact any sector of our economy because our economy needs to be rebuilt and that that any impact must be offset by revenues going back into economic activities that build our province or by directly reducing tax.

KAP President Dan Mazier agrees a carbon pricing system must consider the competitive position of farmers.

Dan Mazier-Keystone Agricultural Producers:

We have no ability to get that tax back out of the system.

We're price takers and it's what ever the market is offering.

Manitoba exports probably 70 percent of their products and, if we're competing against a nation or another place that doesn't have a carbon tax, that is an extra cost that's being borne by our agriculture community that we couldn't compete against so it basically makes us uncompetitive.

That's what a bad system could do.

Source : Farmscape

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.